Lung Cancer Trial, Recruiting (NCT05339568)

Lung Cancer Trial, Recruiting NCT05339568 Sponsor: Qianfoshan Hospital Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05339568 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have fully understood the study and agreed to take part by signing a consent form
People aged 18 or older at the time of signing the consent form
People who have been diagnosed with non-small cell lung cancer (a type of lung cancer) confirmed by a tissue or cell test
People whose lung cancer has been classified as stage IIB, stage III, or stage IV according to standard cancer staging guidelines
People whose cancer has been assessed as not suitable for curative (complete) treatment, or who have chosen not to have surgery
People who are expected to live for at least 3 months
People who are able to use a smartphone

Who may not be able to join:

People who have a mental illness
People who have been diagnosed with any other type of cancer
People who are expected to undergo surgery aimed at fully removing or curing their cancer
People who are currently taking part in another clinical trial
People who the trial doctor considers unsuitable to participate, for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jiandong ZHANG, Shandong First Medical University

Phone: (+86531)89268118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05339568

Sponsor: Qianfoshan Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: (+86531)89268118

More information: https://clinicaltrials.gov/study/NCT05339568

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have fully understood the study and agreed to take part by signing a consent form
People aged 18 or older at the time of signing the consent form
People who have been diagnosed with non-small cell lung cancer (a type of lung cancer) confirmed by a tissue or cell test
People whose lung cancer has been classified as stage IIB, stage III, or stage IV according to standard cancer staging guidelines
People whose cancer has been assessed as not suitable for curative (complete) treatment, or who have chosen not to have surgery
People who are expected to live for at least 3 months
People who are able to use a smartphone

Who may not be able to join:

People who have a mental illness
People who have been diagnosed with any other type of cancer
People who are expected to undergo surgery aimed at fully removing or curing their cancer
People who are currently taking part in another clinical trial
People who the trial doctor considers unsuitable to participate, for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Qianfoshan Hospital

Registry

ClinicalTrials.gov

Start date

22 May 2022

Est. completion

21 April 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov